National survey launched to assess the health impacts of the COVID-19 pandemic
April 05, 2022
Global Korean Post
The Public Health Agency of Canada, Statistics Canada and the COVID-19 Immunity Task Force are conducting a second cycle of the Canadian COVID-19 Antibody and Health Survey.
The first cycle started in 2020 and found that few Canadians had antibodies against SARS-CoV-2 in early 2021.
The second cycle of the study involves sending surveys and test kits to 100,000 Canadians across the ten provinces.
Canadians aged 18 years and older will be randomly selected to create a representative sample and ensure that the results are generalizable to the Canadian adult population.
Individuals who do not receive an invitation to participate in the survey cannot volunteer for the study.
DBS testing is an innovative technology commonly used by scientists at PHAC to screen for transmissible diseases in Canada.
It has a variety of uses such as testing for sexually transmitted, blood-borne infections (STBBIs) and testing for antibodies from previous infections such as COVID-19.
The survey invitations and test kits will be administered during three waves, with wave 1 launched in early April, wave 2 in May, and wave 3 in June.
